$2.95
1.67% yesterday
Nasdaq, Dec 23, 10:00 pm CET
ISIN
US45779A8466
Symbol
NSPR

InspireMD Inc Stock price

$2.95
+0.01 0.34% 1M
+0.41 16.14% 6M
+0.14 4.98% YTD
+0.80 37.21% 1Y
-0.32 9.79% 3Y
-11.45 79.51% 5Y
-4,724,997.05 100.00% 10Y
Nasdaq, Closing price Mon, Dec 23 2024
-0.05 1.67%
ISIN
US45779A8466
Symbol
NSPR
Sector

Key metrics

Market capitalization $76.95m
Enterprise Value $37.78m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.54
P/S ratio (TTM) P/S ratio 11.28
P/B ratio (TTM) P/B ratio 1.83
Revenue growth (TTM) Revenue growth 24.70%
Revenue (TTM) Revenue $6.82m
EBIT (operating result TTM) EBIT $-29.94m
Free Cash Flow (TTM) Free Cash Flow $-20.60m
Cash position $40.40m
EPS (TTM) EPS $-0.84
P/S forward 11.16
EV/Sales forward 5.48
Short interest 0.90%
Show more

Is InspireMD Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.

InspireMD Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a InspireMD Inc forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a InspireMD Inc forecast:

Buy
100%

Financial data from InspireMD Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
6.82 6.82
25% 25%
100%
- Direct Costs 5.28 5.28
33% 33%
77%
1.54 1.54
3% 3%
23%
- Selling and Administrative Expenses 19 19
42% 42%
282%
- Research and Development Expense 12 12
51% 51%
176%
-30 -30
48% 48%
-435%
- Depreciation and Amortization 0.27 0.27
17% 17%
4%
EBIT (Operating Income) EBIT -30 -30
48% 48%
-439%
Net Profit -28 -28
46% 46%
-414%

In millions USD.

Don't miss a Thing! We will send you all news about InspireMD Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

InspireMD Inc Stock News

Neutral
GlobeNewsWire
15 days ago
Study represents a significant step forward in Company's mission to serve the broadest set of physician and patient needs with best-in-class CAS and TCAR solutions Study represents a significant step forward in Company's mission to serve the broadest set of physician and patient needs with best-in-class CAS and TCAR solutions
Neutral
GlobeNewsWire
28 days ago
MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced the appointment of accomplished medical technology executive Scott R. Ward to its Board of Directors. Mr. Ward most recently served as Chief Executive Officer and President of Cardiovascular Systems, Inc. prior to i...
Neutral
Seeking Alpha
about one month ago
InspireMD, Inc. (NASDAQ:NSPR ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Chuck Padala - IR, Life Advisors Marvin Slosman - CEO Craig Shore - CFO Shane Gleason - CCO Conference Call Participants Adam Maeder - Piper Sandler Operator Good day, everyone, and welcome to the InspireMD Third Quarter 2024 Earnings Call. Currently, all participants are in a liste...
More InspireMD Inc News

Company Profile

InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.

Head office United States
CEO Marvin Slosman
Employees 66
Founded 2005
Website www.inspiremd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today